[1] Vall dHebron Inst Oncol, Quironsalud Grp, IOB Inst Oncol, Barcelona, Spain
[2] Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal
[3] Univ Milan, European Inst Oncol, Div Early Drug Dev, IRCSS, Milan, Italy
[4] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA
[5] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea
[6] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[7] Banner MD Anderson Canc Ctr, Breast Canc Program, Gilbert, AZ USA
[8] Univ Pisa, Dept Oncol & Translat Med, Pisa, Italy
[9] Hosp Arnau Vilanova, Lleida, Spain
[10] Mercy Med Ctr, Div Med Oncol & Hematol, Baltimore, MD USA
[11] Univ Parma, Dept Med & Surg, Parma, Italy
[12] Univ Hosp Parma, Med Oncol & Breast Unit, Parma, Italy
[13] Piedmont Canc Inst, Atlanta, GA USA
[14] Portuguese Inst Oncol Porto, Porto, Portugal
[15] Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea
[16] NYU, Dept Med, Perlmutter Canc Ctr, 550 1St Ave, New York, NY 10016 USA
[17] St Lukes Canc Inst, Kansas City, MO USA
[18] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[19] Univ Politecn Marche, Osped Riuniti, Ancona, Italy
[20] MacroGenics Inc, Rockville, MD USA
[21] Stanford Womens Canc Ctr, Breast Canc Oncol Program, Palo Alto, CA USA